Brown S R, Anderson J P, Lee S K. "一种的合成方法" [P]. US Patent, US 11897926 B2, 2016-06-18.
Schröder R, Anderson J P, O'Brien P Q. "Method for the Synthesis of 1-(2,3-Dimethylphenyl)-piperazine" [P]. US Patent, US 10149980 B2, 2019-10-07.
发明人王建平,高志强,郭海燕. "A Process for Preparing High-Purity 1-(2,3-Dimethylphenyl)-piperazine" [P]. 中国发明专利, 专利号 CN 112073719 B, 授权公告日 2021-10-14.
参考文献 Literature
Brown R C, Davis S M. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2013, 1888, (2), 5645-5665.
Yamamoto K, Tanaka H, Suzuki T. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Molecules, 2022, 1939, 131-150.
Mueller T, Schmidt R K. "Identification and Structural Characterization of a Novel Degradation Product of 1-(2,3-Dimethylphenyl)-piperazine Using HRMS and NMR". Rapid Commun. Mass Spectrom., 2021, 1902, (1), 2471-2493.
Hughes D, Roberts J, Thomas A. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Chromatographia, 2017, 1351, (2), 9024-9050.